Theratechnologies Inc
TSX:TH

Watchlist Manager
Theratechnologies Inc Logo
Theratechnologies Inc
TSX:TH
Watchlist
Price: 1.73 CAD
Market Cap: 79.5m CAD
Have any thoughts about
Theratechnologies Inc?
Write Note

Theratechnologies Inc
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Theratechnologies Inc
Research & Development Peer Comparison

Comparables:
B
DRUG
RPTX
AUPH
COV
EDT

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Theratechnologies Inc
TSX:TH
Research & Development
-$16.3m
CAGR 3-Years
15%
CAGR 5-Years
-13%
CAGR 10-Years
-11%
B
Bright Minds Biosciences Inc
CNSX:DRUG
Research & Development
-CA$5m
CAGR 3-Years
-196%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Repare Therapeutics Inc
NASDAQ:RPTX
Research & Development
-$131.8m
CAGR 3-Years
-50%
CAGR 5-Years
-69%
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Research & Development
-$22.9m
CAGR 3-Years
24%
CAGR 5-Years
15%
CAGR 10-Years
-13%
Covalon Technologies Ltd
XTSX:COV
Research & Development
-CA$1.5m
CAGR 3-Years
2%
CAGR 5-Years
-1%
CAGR 10-Years
-13%
Spectral Medical Inc
TSX:EDT
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Theratechnologies Inc's Research & Development?
Research & Development
-16.3m USD

Based on the financial report for Aug 31, 2024, Theratechnologies Inc's Research & Development amounts to -16.3m USD.

What is Theratechnologies Inc's Research & Development growth rate?
Research & Development CAGR 10Y
-11%

Over the last year, the Research & Development growth was 53%. The average annual Research & Development growth rates for Theratechnologies Inc have been 15% over the past three years , -13% over the past five years , and -11% over the past ten years .

Back to Top